193 related articles for article (PubMed ID: 17893275)
1. Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress.
Okumura S; Vatner DE; Kurotani R; Bai Y; Gao S; Yuan Z; Iwatsubo K; Ulucan C; Kawabe J; Ghosh K; Vatner SF; Ishikawa Y
Circulation; 2007 Oct; 116(16):1776-83. PubMed ID: 17893275
[TBL] [Abstract][Full Text] [Related]
2. Cardiac-directed expression of a catalytically inactive adenylyl cyclase 6 protects the heart from sustained β-adrenergic stimulation.
Gao MH; Lai NC; Giamouridis D; Kim YC; Guo T; Hammond HK
PLoS One; 2017; 12(8):e0181282. PubMed ID: 28767701
[TBL] [Abstract][Full Text] [Related]
3. New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: effects of targeted disruption of the type 5 adenylyl cyclase gene.
Okumura S; Suzuki S; Ishikawa Y
J Pharmacol Sci; 2009 Mar; 109(3):354-9. PubMed ID: 19270422
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase.
Vatner DE; Asai K; Iwase M; Ishikawa Y; Wagner TE; Shannon RP; Homcy CJ; Vatner SF
J Clin Invest; 1998 May; 101(9):1916-22. PubMed ID: 9576756
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart.
Vatner DE; Asai K; Iwase M; Ishikawa Y; Shannon RP; Homcy CJ; Vatner SF
Am J Cardiol; 1999 Jun; 83(12A):80H-85H. PubMed ID: 10750593
[TBL] [Abstract][Full Text] [Related]
6. Adenylyl cyclase subtype-specific compartmentalization: differential regulation of L-type Ca2+ current in ventricular myocytes.
Timofeyev V; Myers RE; Kim HJ; Woltz RL; Sirish P; Heiserman JP; Li N; Singapuri A; Tang T; Yarov-Yarovoy V; Yamoah EN; Hammond HK; Chiamvimonvat N
Circ Res; 2013 Jun; 112(12):1567-76. PubMed ID: 23609114
[TBL] [Abstract][Full Text] [Related]
7. Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling.
Tepe NM; Lorenz JN; Yatani A; Dash R; Kranias EG; Dorn GW; Liggett SB
Biochemistry; 1999 Dec; 38(50):16706-13. PubMed ID: 10600134
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of G protein-coupled receptor kinase 2 selectively increases the sensitivity of A2A adenosine receptors to agonist-induced desensitization.
Mundell SJ; Luty JS; Willets J; Benovic JL; Kelly E
Br J Pharmacol; 1998 Sep; 125(2):347-56. PubMed ID: 9786508
[TBL] [Abstract][Full Text] [Related]
9. Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload.
Okumura S; Takagi G; Kawabe J; Yang G; Lee MC; Hong C; Liu J; Vatner DE; Sadoshima J; Vatner SF; Ishikawa Y
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9986-90. PubMed ID: 12904575
[TBL] [Abstract][Full Text] [Related]
10. The type VI adenylyl cyclase protects cardiomyocytes from β-adrenergic stress by a PKA/STAT3-dependent pathway.
Wu YS; Chen CC; Chien CL; Lai HL; Jiang ST; Chen YC; Lai LP; Hsiao WF; Chen WP; Chern Y
J Biomed Sci; 2017 Sep; 24(1):68. PubMed ID: 28870220
[TBL] [Abstract][Full Text] [Related]
11. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
Zeiders JL; Seidler FJ; Slotkin TA
J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
[TBL] [Abstract][Full Text] [Related]
12. Disruption of Epac1 protects the heart from adenylyl cyclase type 5-mediated cardiac dysfunction.
Cai W; Fujita T; Hidaka Y; Jin H; Suita K; Prajapati R; Liang C; Umemura M; Yokoyama U; Sato M; Okumura S; Ishikawa Y
Biochem Biophys Res Commun; 2016 Jun; 475(1):1-7. PubMed ID: 27117748
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
[TBL] [Abstract][Full Text] [Related]
14. Acute depression of myocardial beta-adrenergic receptor signaling during cardiopulmonary bypass: impairment of the adenylyl cyclase moiety. Duke Heart Center Perioperative Desensitization Group.
Booth JV; Landolfo KP; Chesnut LC; Bennett-Guerrero E; Gerhardt MA; Atwell DM; El-Moalem HE; Smith MS; Funk BL; Kuhn CM; Kwatra MM; Schwinn DA
Anesthesiology; 1998 Sep; 89(3):602-11. PubMed ID: 9743395
[TBL] [Abstract][Full Text] [Related]
15. Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade.
Yan L; Vatner SF; Vatner DE
Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1521-8. PubMed ID: 25193472
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of wild-type Galpha(i)-2 suppresses beta-adrenergic signaling in cardiac myocytes.
Rau T; Nose M; Remmers U; Weil J; Weissmüller A; Davia K; Harding S; Peppel K; Koch WJ; Eschenhagen T
FASEB J; 2003 Mar; 17(3):523-5. PubMed ID: 12631586
[TBL] [Abstract][Full Text] [Related]
17. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cyclic adenosine monophosphate release by selective β2-adrenergic receptor stimulation in human terminal failing myocardium before and after ventricular assist device support.
Kassner A; Toischer K; Bohms B; Kolkhof P; Abraham G; Hasenfuβ G; Morshuis M; Schulte Eistrup S; El-Banayosy A; Gummert J; Milting H
J Heart Lung Transplant; 2012 Oct; 31(10):1127-35. PubMed ID: 22975104
[TBL] [Abstract][Full Text] [Related]
19. Adenylyl cyclase type VI increases Akt activity and phospholamban phosphorylation in cardiac myocytes.
Gao MH; Tang T; Guo T; Miyanohara A; Yajima T; Pestonjamasp K; Feramisco JR; Hammond HK
J Biol Chem; 2008 Nov; 283(48):33527-35. PubMed ID: 18838385
[TBL] [Abstract][Full Text] [Related]
20. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.
Oudit GY; Crackower MA; Eriksson U; Sarao R; Kozieradzki I; Sasaki T; Irie-Sasaki J; Gidrewicz D; Rybin VO; Wada T; Steinberg SF; Backx PH; Penninger JM
Circulation; 2003 Oct; 108(17):2147-52. PubMed ID: 12963636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
